We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What is Metamizole?

By M. Haskins
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Metamizole, also known as metamizole sodium, is a non-steroidal anti-inflammatory drug (NSAID) similar to aspirin and ibuprofen that works as an analgesic, meaning it provides pain relief, and as an antipyretic, meaning it reduces fever. This drug was originally available without a prescription in most countries, but has been banned in more than 30 countries since the 1970s when its use was linked to a rare but sometimes fatal condition called agranulocytosis. The actual danger of taking metamizole is a matter of scientific debate, and in many countries the drug is still available over the counter and is used as part of pain and fever management in hospitals. In other countries, it is available, but only with a prescription. It is sold under many different brand names, including Dipyrone, Analgin, and Novalgin.

Until the 1970s, when the link to agranulocytosis was made, metamizole was generally considered a safe and effective NSAID that was especially potent when it came to reducing fever. It is still available over the counter in, for example, Spain, India, Mexico, Israel, and Russia, as well as many developing countries. In these countries it is often a popular drug that is considered both inexpensive and effective. Metamizole is currently banned in the United States, Canada, Sweden, Japan, Australia, and several other countries.

Agranulocytosis is a very serious condition characterized by a low white blood cell count and a suppressed immune system. Those suffering from this condition are very susceptible to infections like pneumonia and septicemia, also known as blood poisoning. Common symptoms include fever and sore throat, but are not present in all cases. This potentially fatal condition is a possible side effect not only of metamizole, but also of several other drugs, including other NSAIDs, such as naproxen, and the commonly prescribed anti-psychotic drug clozapine.

Many scientific studies have been done on the connection between metamizole and agranulocytosis, but they do not all agree on the risk of contracting the condition when taking the drug. Proponents of this drug believe that the risks were overestimated in the 1970s. Some recent studies have concluded that the risk is comparable to, or even lower than, the risk related to other medications. However, other studies have concluded that the risk of harmful side effects, including not only agranulocytosis, but also anaphylaxis and infant leukemia, is too great to allow the medication to be used. Those opposed to the use of metamizole believe it is preferable to use other drugs not associated with these risks.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Discussion Comments
By anon942258 — On Mar 26, 2014

The risk is very small. If you are in severe pain, and over 18, it is worth considering.

By JessicaLynn — On Jul 19, 2011

@JaneAir - I'm a little bit disturbed that agranulocytosis is a possible side effect of naproxen! That is sold over the counter here in the US as Aleve and I take it pretty frequently.

I usually read warning labels on things and I don't remember any bottle of naproxen ever having a warning about that on it.

By JaneAir — On Jul 18, 2011

One of my friends had septicemia in college. She almost died! It's definitely not something to play around with. Even if this drug is available to you I would strongly suggest not taking it!

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.